Advertisement

Topics

Latest "Locus Discovery Incorporated" News Stories

15:43 EDT 23rd September 2018 | BioPortfolio

Here are the most relevant search results for "Locus Discovery Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Locus Discovery Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Locus Discovery Incorporated for you to read. Along with our medical data and news we also list Locus Discovery Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Locus Discovery Incorporated Companies for you to search.

Showing "Locus Discovery Incorporated" News Articles 1–25 of 4,400+

Saturday 22nd September 2018

CombiChem, ICOS to Expand Drug Discovery/ Development Collaboration

CombiChem Inc. (San Diego) and ICOS Corp. (Bothell, WA) have expanded their previously established drug discovery and development collaboration with the addition of an undisclosed target...


Charles River Laboratories International Inc CRL Medical Equipment Deals and Alliances Profile [Report Updated: 24042018] Prices from USD $250

SummaryCharles River Laboratories International Inc Charles River is a contract research organization CRO that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical, manufacturing and operations and staffing support. It focuses on pro...

Friday 21st September 2018

Discovery of vibrant deep-sea life prompts new worries over seabed mining


Discovery of Galileo’s long-lost letter shows he edited his heretical ideas to fool the Inquisition

Researchers Have Finally Found Human Skeletal Stem Cells

If only we could regrow our broken bones like Harry Potter, Skele-gro style. Or, at the very least, heal up like a limb-regenerating newt. Alas, we humans possess no such abilities. Though our bodies can mend broken bones, the older we get, the shoddier that patch job gets. As for cartilage — the crucial cushioning that keeps our bones from rubbing together — once that’s gone, it’s gone fo...

Genome-wide analysis of polymorphism × sodium interaction effect on blood pressure identifies a novel 3′-BCL11B gene desert locus

Genomic Study Brings Us Closer to Precision Medicine for Type 2 Diabetes

NewsAnalysis reveals disease's complexity, suggests potential clinical subtypes defined by genetics and physiology.Contributed Author:&nbs

Ichor's Auctus Biologics Closes Quick $1.5MM

Auctus Biologics, Inc., a new portfolio company of Ichor Therapeutics, Inc., announced today the closure of $1.5MM in seed funding. The company will develop RPtag, a hyper-stable antibody mimetic scaffold published earlier th

Enigma Biomedical and Invicro Sign a Memorandum of Understanding to Co-Develop Synaptic Density Biomarker Imaging

Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to cooperate in the development of Synaptic Density Biomarker Imaging (“SDI”). SDI promises to provide an important new tool in understanding neurodegen...

Molecular Templates and Takeda Enter Agreement for the Joint Development of a Protein-Based Oncology Therapy

AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq:MTEM) today announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the joint development of CD38-targeted engineered toxin bodies (ETBs) for the treatment of patients with diseases such as multiple myeloma. The lead development candidate is a CD38-targeted ETB that resulted from a pre...

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Previously Treated Non-Small Cell Lung Cancer at Annual Meeting of the Chinese Society of Clinical Oncology

SUZHOU, China, Sept. 21, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical research data on cohort C at the 2018 Annual Meeting of Chinese Society of Clinical Oncology (CSCO). The study is a phase Ib clinical trial (NCT02937116) in which NSCLC patients with dise...

Hesperos, Inc. Among GrowFL 2018 Florida Companies to Watch

Hesperos, Inc. has announced that it has been named one of the 50 statewide companies expected to see significant growth over the next several years by GrowFL. The 50 companies were selected from more than 500 nominees for Florida Companies to WatchSM, a statewide program managed by economic development group GrowFL, in association with the Edward Lowe Fou...

Lymphoma Research Foundation Hosts New York City Biden Cancer Community Summit

Summit to Explore National Efforts to Support the Next Generation of Lymphoma Scientists NEW YORK (PRWEB) September 21, 2018 The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to the eradication of lymphoma – will today host a Biden Cancer Summit in New York City to explore the challenges faced by scientists seeking to pursue a career i...

uBiome Announces $83 Million Series C Financing

uBiome Will Expand World’s Largest Human Microbiome Database and Advance Product Portfolio, Including Drug Discovery & Development uBiome, the leader in microbial genomics, today announced the Company has raised $83 million in Series C financing. OS Fund led the round, with participation from 8VC, Y Combinator, Dentsu Ventures, and additional new...

uBiome Announces Expansion into Microbiome-Based Therapeutics, Appoints Pharmaceutical Veteran Joseph Jimenez to Board of Directors

uBiome Opens Therapeutics Headquarters in Cambridge, Massachusetts to Support Drug Discovery and Development Initially Focused on Therapeutics for Oncology, Autoimmune Disorders, Obesity, and Metabolic Disorders uBiome, the leader in microbial genomics, today announced that the company will leverage its deep knowledge of the microbio...

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Advanced Malignant Neuroendocrine Tumors at Annual Meeting of the Chinese Society of Clinical Oncology

SUZHOU, China, Sept. 21, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical trial data from a phase Ib clinical trial (NCT02937116) that treated patients with neuroendocrine tumors (NET) who have failed of standard therapy with single agent sintilimab, a fully hu...

A behavioural intervention for cancer patients that works

This is a story about something rare in health psychology: a treatment that has gone from scientific discovery, through development and testing, to dissemination and successful implementation nationwide. In a new study, researchers found that a program...

SCIEX Presenting New Applications at Global CESI-MS Symposium 2018

Innovations in ultra low-flow separation and accurate mass analysis expands into proteomics, metabolomics, food and environmental monitoring SCIEX, a global leader in life science analytical technologies, today announced new applications for CESI-MS, its breakthrough technology for discovering previously undetectable characteristics in small samples. ...

Receptor Tyrosine Protein Kinase ERBB 3 Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1 Pipeline Review, H2 2018 [Report Updated: 10072018] Prices from USD $3500

Receptor Tyrosine Protein Kinase ERBB 3 Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1 Pipeline Review, H2 2018SummaryAccording to the recently published report 'Receptor Tyrosine Protein Kinase ERBB 3 Pipeline Review, H2 2018'; Receptor Tyrosine Protein Kinase ERBB 3 Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase ...

How one company is empowering synthetic biology by making high-fidelity DNA at scale

This article is brought to you by DCVC (Data Collective), a leading deep tech and synthetic biology venture capital firm that backs entrepreneurs solving some the world’s hardest problems computationally — from industrial biotech to algorithmic drug discovery to smart […] The post How one company is empowering synthetic biology by making high-fidelity DNA at scale appeared first on S...

Thursday 20th September 2018

World Alzheimer Report 2018: The State of the art of dementia research: New frontiers

21 September 2018 - The World Alzheimer Report 2018, released today, addresses key questions in dementia research, relating to: basic science, diagnosis, drug discovery, risk reduction, epidemiology and care. Find out what the leading lights in dementia research globally have to say. [read more]

Innovate UK funds AI drug discovery platform

Innovate UK has been awarded a grant to support the development of an artificial intelligence (AI) drug discovery project by...Read More... The post Innovate UK funds AI drug discovery platform appeared first on Pharmaceutical Technology.

Study Reveals a Promising Alternative to Corticosteroids in Acute Renal Failure Treatment

NewsIn search of an option for the drug known for causing several side effects, scientists describe the anti-inflammatory properties of protein galectin-1 in tests with rats involving ischemia-reperfusion scenarios.

Human Skeletal Stem Cells Found

(The Scientist) – Three years after its discovery of skeletal stem cells in mice, the same research team has identified the human version of this precursor to bone, cartilage, and stroma, the bone marrow’s support cells. In a study published … Read More

Johns Hopkins All Children’s Hospital Opens Largest Pediatric Research and Education Building in Region

Johns Hopkins All Children’s Research and Education building officially opens, making it the largest pediatric research and teaching facility in the region. ST. PETERSBURG, Fla. (PRWEB) September 20, 2018 The Johns Hopkins All Children’s Research and Education building officially opened today, making it the largest pediatric research and teaching facility in the region. The research and educa...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks